Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.

PURPOSE To assess whether normal myocardium can be distinguished from infarction at magnetic resonance (MR) imaging with low doses of manganese dipyridoxyl diphosphate (Mn-DPDP). MATERIALS AND METHODS After 1-hour coronary arterial occlusion and 2-hour reperfusion, three groups of eight rats each were injected with 25, 50, or 100 micromol of Mn-DPDP per kilogram of body weight. The longitudinal relaxation rate (R1) in normal myocardium, reperfused infarction, and blood was repeatedly measured at inversion-recovery echo-planar imaging before and for 1 hour after the administration of contrast material. Afterward, several animals from each group were examined at high-spatial-resolution inversion-recovery spin-echo (SE) MR imaging. RESULTS Manganese accumulated in normal myocardium but was cleared from reperfused infarction and blood. One hour after the administration of Mn-DPDP, R1 in normal myocardium (1.53 sec(-1) +/- 0.03, 1.73 sec(-1) +/- 0.03, and 1.94 sec(-1) +/- 0.02, respectively, for 25, 50, and 100 micromol/kg) was significantly (P <.05) faster than that of reperfused infarction (0.99 sec(-1) +/- 0.03, 1.11 sec(-1) +/- 0.03, and 1.48 sec(-1) +/- 0.06). Normal myocardium appeared hyperintense on T1-weighted inversion-recovery SE MR images and was clearly distinguishable from reperfused infarction. CONCLUSION Mn-DPDP-enhanced inversion-recovery echo-planar and SE MR images demonstrated retention of manganese in normal myocardium and clearance of manganese from infarction. Mn-DPDP has characteristics similar to those of widely used thallium and may be useful in the assessment of myocardial viability at MR imaging.

[1]  H. Selye,et al.  Simple Techniques for the Surgical Occlusion of Coronary Vessels in the Rat , 1960, Angiology.

[2]  F. Buonanno,et al.  Quantification of Experimental Myocardial Infarction Using Nuclear Magnetic Resonance Imaging and Paramagnetic Ion Contrast Enhancement in ExcisedCanine Hearts , 1982, Circulation.

[3]  P C Lauterbur,et al.  Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. , 1983, Seminars in nuclear medicine.

[4]  H. Refsum,et al.  Cardiovascular safety of MnDPDP and MnCl2 , 1997, Acta radiologica.

[5]  R. Haworth,et al.  Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. , 1981, Journal of molecular and cellular cardiology.

[6]  T. Southon,et al.  Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration , 1997, Acta radiologica.

[7]  H. Hope,et al.  Physicochemical characterisation of mangafodipir trisodium , 1997, Acta radiologica.

[8]  E. Holtz,et al.  Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. , 1994, Investigative radiology.

[9]  H. Brurok,et al.  Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese. , 1997, Acta physiologica Scandinavica.

[10]  C. Higgins,et al.  Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging. , 1989, Radiology.

[11]  G L Wolf,et al.  Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. , 1983, AJR. American journal of roentgenology.

[12]  C. Higgins,et al.  Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP. , 1989, Investigative radiology.

[13]  M E Moseley,et al.  A model of acute regional myocardial ischemia and reperfusion in the rat , 1989, Magnetic resonance in medicine.

[14]  R. Chapman,et al.  Uptake and loss of manganese from perfused frog ventricles. , 1977, The Journal of physiology.

[15]  G A Beller,et al.  Differentiation of Transiently Ischemic from Infarcted Myocardium by Serial Imaging after a Single Dose of Thallium‐201 , 1977, Circulation.

[16]  W. Ashburn,et al.  Comparative myocardial uptake of intravenously administered radionuclides. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  G. Bačić,et al.  Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn‐DPDP , 1996, Magnetic resonance in medicine.

[18]  J Sykes,et al.  Assessment of myocardial viability using MRI during a constant infusion of Gd‐DTPA: Further studies at early and late periods of reperfusion , 1999, Magnetic resonance in medicine.

[19]  L. Vander Elst,et al.  Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart. , 1997, Investigative radiology.

[20]  C. Higgins,et al.  T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging , 2000, European Radiology.

[21]  H. Brurok,et al.  Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. , 1997, Investigative radiology.

[22]  F. Buonanno,et al.  Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. , 1982, Radiology.

[23]  T. Skotland,et al.  Metabolism and pharmacokinetics of MnDPDP in man , 1997, Acta radiologica.

[24]  H. Atkins,et al.  Myocardial positron tomography with manganese-52m. , 1979, Radiology.

[25]  F J Schoen,et al.  Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. , 1985, The American journal of pathology.

[26]  R. Kloner,et al.  Effect of early coronary artery reperfusion on infarct development in a model of low collateral flow. , 1987, Cardiovascular research.

[27]  H. Brurok,et al.  Effects of Manganese Dipyridoxyl Diphosphate, Dipyridoxyl Diphosphate– –, and Manganese Chloride on Cardiac Function: An Experimental Study in the Langendorff Perfused Rat Heart , 1995, Investigative radiology.

[28]  G. Elizondo,et al.  Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. , 1991, Radiology.

[29]  S. Hauptmann,et al.  Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. , 1993, Radiology.

[30]  C. Higgins,et al.  Distribution of intracellular, extracellular, and intravascular contrast media for magnetic resonance imaging in hearts subjected to reperfused myocardial infarction. , 1996, Academic radiology.

[31]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[32]  A. Salustri,et al.  Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. , 1994, The American journal of cardiology.

[33]  Kenneth N. Raymond,et al.  Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement , 1989 .

[34]  C. Higgins,et al.  Alterations in T 1 of normal and reperfused infarcted myocardium after Gd‐BOPTA versus GD‐DTPA on inversion recovery EPI† , 1997, Magnetic resonance in medicine.

[35]  C M Kramer,et al.  Usefulness of magnetic resonance imaging early after acute myocardial infarction. , 1997, The American journal of cardiology.

[36]  L S MAYNARD,et al.  The partition of manganese among organs and intracellular organelles of the rat. , 1955, Journal of Biological Chemistry.

[37]  H. Schelbert,et al.  Insights Into Coronary Artery Disease Gained From Metabolic Imaging , 1988, Circulation.

[38]  V. Dilsizian,et al.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. , 1990, The New England journal of medicine.

[39]  C B Higgins,et al.  Acute myocardial ischemia: MR imaging with Mn-TP. , 1988, Radiology.

[40]  R W Parkey,et al.  In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate. , 1989, Journal of the American College of Cardiology.

[41]  C. Higgins,et al.  Identification of Myocardial Cell Death in Reperfused Myocardial Injury Using Dual Mechanisms of Contrast-Enhanced Magnetic Resonance Imaging , 1994 .

[42]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[43]  B. Hamm,et al.  Manganese‐DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients , 1991, Investigative radiology.

[44]  H R Schelbert,et al.  Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[46]  J. Ardenkjaer-Larsen,et al.  Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? , 1999, Biochemical and biophysical research communications.

[47]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.

[48]  M. Laks,et al.  Comparison of electron beam computed tomography scanning and magnetic resonance imaging quantification of right ventricular mass: validation with autopsy weights. , 1996, Academic radiology.